Maternal SARS-CoV-2 Vaccination and Infant Protection Against SARS-CoV-2 During the First 6 Months of Life

We examined the effectiveness of maternal vaccination against SARS-CoV-2 infection in 30,288 infants born at Kaiser Permanente Northern California from December 15, 2020, to May 31, 2022. Using Cox regression, the effectiveness of maternal vaccination was 85% (95% confidence interval [CI]: 67, 93),...

Descripción completa

Detalles Bibliográficos
Autores principales: Zerbo, Ousseny, Ray, G. Thomas, Fireman, Bruce, Layefsky, Evan, Goddard, Kristin, Lewis, Edwin, Ross, Pat, Omer, Saad, Greenberg, Mara, Klein, Nicola
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Journal Experts 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9603829/
https://www.ncbi.nlm.nih.gov/pubmed/36299419
http://dx.doi.org/10.21203/rs.3.rs-2143552/v1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9603829/
https://www.ncbi.nlm.nih.gov/pubmed/36299419
http://dx.doi.org/10.21203/rs.3.rs-2143552/v1

Ejemplares similares